- Home
- BGY vs CYRX Comparison
BGY vs CYRX Comparison
Compare BGY & CYRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | BGY | CYRX |
|---|---|---|
| Founded | 2007 | 1999 |
| Country | United States | United States |
| Employees | N/A | 1100 |
| Industry | Trusts Except Educational Religious and Charitable | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 515.6M | 419.3M |
| IPO Year | N/A | 2008 |
Fundamental Metrics
Financial Performance| Metric | BGY | CYRX |
|---|---|---|
| Price | $5.73 | $14.77 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 8 |
| Target Price | N/A | ★ $13.31 |
| AVG Volume (30 Days) | 357.4K | ★ 816.2K |
| Earning Date | 01-01-0001 | 05-04-2026 |
| Dividend Yield | ★ 7.41% | N/A |
| EPS Growth | N/A | ★ 156.22 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $176,177,000.00 |
| Revenue This Year | N/A | $11.06 |
| Revenue Next Year | N/A | $8.45 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $5.19 | $6.69 |
| 52 Week High | $6.23 | $16.73 |
Technical Indicators
Market Signals| Indicator | BGY | CYRX |
|---|---|---|
| Relative Strength Index (RSI) | 50.32 | 53.76 |
| Support Level | $5.69 | $14.29 |
| Resistance Level | $5.87 | $16.73 |
| Average True Range (ATR) | 0.08 | 0.64 |
| MACD | 0.00 | -0.24 |
| Stochastic Oscillator | 54.90 | 14.52 |
Price Performance
Historical ComparisonAbout BGY Blackrock Enhanced International Dividend Trust
Blackrock Enhanced International Dividend Trust is a diversified closed-end management investment company. Its primary investment objective is to provide current income and current gains, with a secondary objective of long-term capital appreciation. The Trust invests the majority of its net assets in dividend-paying equity securities issued by non-U.S. companies of any market capitalization, with a key focus on securities of large capitalization companies. It invests directly in such securities or synthetically through the use of derivatives.
About CYRX CryoPort Inc.
CryoPort Inc is a provider of integrated, temperature-controlled supply chain solutions for the life sciences industry, with a focus on supporting the cell and gene therapy market. The company provides services such as temperature-controlled logistics, biostorage, bioservices, cryopreservation solutions, and cryogenic systems manufacturing. It operates through two reportable segments: Life Sciences Services and Life Sciences Products. It generates the majority of its revenue from the Life Sciences Services segment.